Clinical Laboratory, the Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, P.R. China.
Department of Experimental Diagnosis, Heilongjiang Provincial Hospital, Harbin, 150036, P.R. China.
J Microbiol Biotechnol. 2020 Mar 28;30(3):459-468. doi: 10.4014/jmb.1910.10041.
This study established a new polymerase spiral reaction (PSR) that combines with reverse transcription reactions for HCV detection targeting 5'UTR gene. To avoid cross-contamination of aerosols, an isothermal amplification tube (IAT), as a separate containment control, was used to judge the result. After optimizing the RT-PSR reaction system, its effectiveness and specificity were tested against 15 different virus strains which included 8 that were HCV positive and 7 as non-HCV controls. The results showed that the RT-PSR assay effectively detected all 8 HCV strains, and no false positives were found among the 7 non-HCV strains. The detection limit of our RT-PSR assay is comparable to the real-time RT-PCR, but is more sensitive than the RT-LAMP. The established RT-PSR assay was further evaluated for detection of HCV in clinical blood samples, and the resulting 80.25% detection rate demonstrated better or similar effectiveness compared to the RT-LAMP (79.63%) and real-time RT-PCR (80.25%). Overall, the results showed that the RT-PSR assay offers high specificity and sensitivity for HCV detection with great potential for screening HCV in clinical blood samples.
本研究建立了一种新的聚合酶螺旋反应(PSR),该反应与针对 5'UTR 基因的 HCV 检测的逆转录反应相结合。为了避免气溶胶的交叉污染,使用了一个等温扩增管(IAT)作为单独的封闭控制来判断结果。在优化 RT-PSR 反应系统后,对其针对 15 种不同病毒株的有效性和特异性进行了测试,其中包括 8 种 HCV 阳性和 7 种非 HCV 对照。结果表明,RT-PSR 检测法有效地检测了所有 8 株 HCV,而在 7 株非 HCV 株中未发现假阳性。我们的 RT-PSR 检测法的检测限与实时 RT-PCR 相当,但比 RT-LAMP 更敏感。进一步评估了建立的 RT-PSR 检测法用于检测临床血液样本中的 HCV,得到的 80.25%的检测率与 RT-LAMP(79.63%)和实时 RT-PCR(80.25%)相比显示出更好或相似的效果。总的来说,结果表明 RT-PSR 检测法具有很高的 HCV 检测特异性和敏感性,具有在临床血液样本中筛查 HCV 的巨大潜力。